AEON AEON Biopharma, Inc.
NYSE · SEC CIK 1837607 · EDGAR
- Bought, last 12 months
- $243.5K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 53 since 2023-07-24, latest 2026-08-21 19:41
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| LYNCH TIMOTHY P | 10% | $243.5K | — |
| Bancroft Robert E. | Pres, CEO, Dir | — | — |
| Sy Jennifer | PRINCIPAL ACCOUNTING Off | — | — |
| Wilson Alexander Blair | CLO, CSO, Corp Sec | — | — |
| Oh Chad | Chief MEDICAL Off | — | — |
| Forth Marc | Dir | — | — |
| Bencich John | CFO | — | — |
| Carter Eric G | Dir | — | — |
| FISCHER JOST | Dir | — | — |
| Thunen Shelley B | Dir | — | — |
Transactions 27
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 19:41 | 2026-08-19 | AEON | LYNCH TIMOTHY P | 10% | P - Purchase | $0.2117 | +1.15M | 6.50M | +21% | +$243.5K | |
| 2026-06-22 18:22 | 2026-06-17 | AEON | Thunen Shelley B | Dir | A - Grant | $0.00 | +222.7K | 258.7K | +618% | $0 | |
| 2026-06-22 18:20 | 2026-06-17 | AEON | PALMISANO ROBERT J | Dir | A - Grant | $0.00 | +222.7K | 258.7K | +618% | $0 | |
| 2026-06-22 18:19 | 2026-06-17 | AEON | Forth Marc | Dir | A - Grant | $0.00 | +222.7K | 973.2K | +30% | $0 | |
| 2026-06-22 18:17 | 2026-06-17 | AEON | FISCHER JOST | Dir | A - Grant | $0.00 | +222.7K | 489.5K | +83% | $0 | |
| 2026-06-22 18:16 | 2026-06-17 | AEON | Carter Eric G | Dir | A - Grant | $0.00 | +222.7K | 258.7K | +618% | $0 | |
| 2026-04-03 18:22 | 2026-04-02 | AEON | Bencich John | CFO | A - Grant | $0.00 | +754.7K | 754.7K | New | $0 | |
| M | 2026-03-11 | 2026-02-17+ | AEON | Oh Chad | Chief MEDICAL Off | A - Grant | $0.00 | +2.18M | 2.18M | +53,626% | $0 |
| M | 2026-03-05 | 2026-02-17+ | AEON | Wilson Alexander Blair | CLO, CSO, Corp Sec | A - Grant | $0.00 | +2.18M | 2.18M | +59,988% | $0 |
| M | 2026-03-05 | 2026-02-17+ | AEON | Sy Jennifer | PRINCIPAL ACCOUNTING Off | A - Grant | $0.00 | +1.50M | 1.50M | +597,978% | $0 |
| 2026-02-19 | 2026-02-17 | AEON | Bancroft Robert E. | Pres, CEO, Dir | A - Grant | $0.00 | +3.00M | 3.18M | +1,694% | $0 | |
| 2025-05-23 | 2025-05-21 | AEON | FISCHER JOST | Dir | P - Purchase | $0.49 | +60.0K | 266.8K | +29% | +$29.4K | |
| M | 2025-05-21 | 2025-05-19+ | AEON | FISCHER JOST | Dir | P - Purchase | $0.5055 | +110.0K | 146.8K | +299% | +$55.6K |
| 2025-05-16 | 2025-05-14 | AEON | Bancroft Robert E. | Pres, CEO, Dir | A - Grant | $0.00 | +177.1K | 177.1K | New | $0 | |
| A | 2024-09-10 | 2024-08-31 | AEON | PALMISANO ROBERT J | Dir | A - Grant | $0.00 | +36.0K | 36.0K | New | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | Oh Chad | Chief MEDICAL Off | A - Grant | $0.00 | +192.1K | 292.5K | +191% | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | Carter Eric G | Dir | A - Grant | $0.00 | +36.0K | 36.0K | New | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | Sy Jennifer | PRINCIPAL ACCOUNTING Off | A - Grant | $0.00 | +18.0K | 18.0K | New | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | Thunen Shelley B | Dir | A - Grant | $0.00 | +36.0K | 36.0K | New | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | Wilson Alexander Blair | EVP, CLO, CORP Sec | A - Grant | $0.00 | +180.1K | 261.5K | +221% | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | FISCHER JOST | Dir | A - Grant | $0.00 | +36.0K | 96.8K | +59% | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | Forth Marc | Chief EXECTUIVE Off, Dir | A - Grant | $0.00 | +470.7K | 750.5K | +168% | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | PALMISANO ROBERT J | Dir | A - Grant | $0.00 | +36.0K | 36.0K | New | $0 |
| 2023-08-14 | 2023-08-11 | AEON | Strathspey Crown Holdings Group, LLC | 10% | S - Sale | $10.00 | -7.38M | 2.03M | -78% | -$73.80M | |
| D | 2023-07-26 | 2023-07-21 | AEON | Grodnensky Oleg | 10% | C - Cnv Deriv | — | +6.90M | 6.90M | New | — |
| DI | 2023-07-26 | 2023-07-21 | AEON | Grodnensky Oleg | 10% | C - Cnv Deriv | — | +89.2K | 6.99M | +1% | — |
| DM | 2023-07-24 | 2023-07-21 | AEON | FISCHER JOST | Dir | A - Grant | — | +15.6K | 2,353 | New | — |
Purchase Sale Sale after option exercise All abbreviations